Abstract
dc:description.abstractCancer treatment strategies often rely on combination therapies that can be aggressive, time-consuming, and present severe side effects. To overcome these challenges, we have developed a modular therapeutic platform for targeted cell killing using self-assembling DNA nanopores (NPs). This study focuses on designing 6-helix bundle NP, featuring hydrophobic moieties that enable membrane insertion, leading to uncontrolled ion flow and ultimately to cell death. These NPs are conjugated site-specifically to rituximab, a CD20-targeting monoclonal antibody, using a dibromopyridazinedione-linker which rebridges interchain disulphides. This conjugation results in a precise 4:1 NP-to-antibody ratio, ensuring targeted delivery and cytotoxicity in B lymphocyte cells.<br/>The NPs were synthesised in a one-step assembly process and verified using electromobility shift assays (EMSA). Successful conjugation was demonstrated through SDS-PAGE, and flow cytometry confirmed the preservation of the antibody's specificity to the CD20 receptor. Furthermore, the stability of the construct was verified in serum over a three-week period at 37°C. In co-culture with a malignant B-cell line (Ramos), the cholesterol-modified NPs exhibited a 20% increase in cell death compared to untreated controls after 48 hours.<br/>This work describes the development of a stable and specific antibody-NP conjugate with defined antibody-drug ratios. The findings elucidate the potential of membrane-spanning NPs as a novel therapeutic platform for cancer treatment, with implications for future applications in various types of cancer.
Degree
thesis:*- Name dc:type.qualificationname
- Ph.D.
- Level dc:type.qualificationlevel
- doctoral
- Grantor dc:publisher.institution
- University of Southampton
- Year dc:date.issued
- 2025
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Ho, Tina-Thien
- Advisors dc:contributor.advisor
-
- Stulz, Eugen
- Lim, Sean
- ORCID person:identifier.orcid
Rights
- Language dc:language
- English, eng